The Toledo, OH-based healthcare real estate investment trust has been forecast by Wall Street to report funds from operations of $1.12 per share on revenue of $973.72 million.
The REIT posted normalized funds from operations of $1.03 on revenue of $867.77 million during the same quarter last year.
Funds from operations is a closely followed metric in the REIT industry, which takes net income and adds back items such as depreciation and amortization.
Welltower's portfolio includes a range of seniors housing and healthcare real estate, including seniors housing communities, nursing facilities, medical office buildings, inpatient and outpatient medical centers and life science facilities.
Separately, TheStreet Ratings Team has a "Buy" rating with a score of B on the stock.
This is driven by several positive factors, which should have a greater impact than any weaknesses, and should give investors a better performance opportunity than most stocks covered.
The company's strengths can be seen in multiple areas, such as its revenue growth, impressive record of earnings per share growth, compelling growth in net income, reasonable valuation levels and good cash flow from operations.
The team feels its strengths outweigh the fact that the company has had lackluster performance in the stock itself.
Recently, TheStreet Ratings objectively rated this stock according to its "risk-adjusted" total return prospect over a 12-month investment horizon. Not based on the news in any given day, the rating may differ from Jim Cramer's view or that of this articles's author.
You can view the full analysis from the report here: HCNHCN data by YCharts